| Number of patients with decreased levels | Number of patients with unchanged or increased levels | Total number of patients |
---|---|---|---|
RANKL | 145 (83 %) | 29 (17 %) | 174 |
IL-6 | 120 (68 %) | 56 (32 %) | 176 |
TNF-RI | 124 (70 %) | 52 (30 %) | 176 |
ACPA | 107 (89 %) | 13 (11 %) | 120 |
Anti-cit-enolase (amino acids 5–21) | 58 (82 %) | 13 (18 %) | 71 |
Anti-cit-vimentin (amino acids 60–75) | 59 (88 %) | 8 (12 %) | 67 |
Anti-cit-fibrinogen (amino acids 563–583) | 35 (83 %) | 7 (17 %) | 42 |